Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 24, 2022 22:32 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Exercise / conversionPerformance Shares · Derivative | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006616 · form4.xml · derivative · entry 3 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,851 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:32 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 1,002 | $319.86 | $320,499.72 |
DisclosureSEC source: 0001127602-22-006616 · form4.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:32 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Exercise / conversionCommon Stock | 2,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006616 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Exercise / conversionPerformance Shares · Derivative | 3,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006626 · form4.xml · derivative · entry 3 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,421 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 944 | $319.86 | $301,947.84 |
DisclosureSEC source: 0001127602-22-006626 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,734 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:36 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Exercise / conversionCommon Stock | 3,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006626 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F2 · balance_after: Balance includes 49 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:34 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
Exercise / conversionPerformance Shares · Derivative | 3,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006621 · form4.xml · derivative · entry 3 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,979 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 7, 2019. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 7, 2019. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 7, 2019. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:34 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
Tax withholdingCommon Stock | 1,521 | $319.86 | $486,507.06 |
DisclosureSEC source: 0001127602-22-006621 · form4.xml · nonDerivative · entry 2 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,303 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:34 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
Exercise / conversionCommon Stock | 3,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006621 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 7, 2019. F2 · balance_after: Balance includes 56 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:30 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006612 · form4.xml · derivative · entry 3 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,561 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:30 UTC |
Dadswell CharlesSVP & General Counsel
|
Tax withholdingCommon Stock | 1,808 | $319.86 | $578,306.88 |
DisclosureSEC source: 0001127602-22-006612 · form4.xml · nonDerivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 6,081 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:30 UTC |
Dadswell CharlesSVP & General Counsel
|
Exercise / conversionCommon Stock | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006612 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 7,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F2 · balance_after: Balance includes 45 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 21:48 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 800 | $425.00 | $340,000.00 |
DisclosureSEC source: 0001127602-22-001460 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,274 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| January 08, 2022 Filed Jan 11, 2022 22:05 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 115 | $362.28 | $41,662.20 |
DisclosureSEC source: 0001127602-22-001336 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,208 Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:10 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $387.06 | $38,706.00 |
DisclosureSEC source: 0001127602-21-032053 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,074 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:37 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 322 | $380.29 | $122,453.38 |
DisclosureSEC source: 0001127602-21-031869 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 3,283 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| December 08, 2021 Filed Dec 9, 2021 21:32 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $375.00 | $37,500.00 |
DisclosureSEC source: 0001127602-21-030603 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,174 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:16 UTC |
Dadswell CharlesSVP, General Counsel
|
SaleCommon Stock | 314 | $377.86 | $118,648.04 |
DisclosureSEC source: 0001110803-21-000047 · primary_doc.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 3,605 F1 · shares: The sale was made pursuant to a 10b5-1 trading plan. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:52 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 361 | $386.35 | $139,472.35 |
DisclosureSEC source: 0001127602-21-029346 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,127 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 08, 2021 Filed Nov 9, 2021 21:59 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 1,000 | $406.83 | $406,830.00 |
DisclosureSEC source: 0001127602-21-028723 · form4.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,015 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 23:52 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantPerformance Shares · Derivative | 1,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028745 · form4.xml · derivative · entry 2 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,226 Underlying: Common Stock · 1,226 shares Expires 2023-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 23:52 UTC |
Pegels Kevin CarlChief of Global Operations
|
Tax withholdingCommon Stock | 574 | $408.14 | $234,272.36 |
DisclosureSEC source: 0001127602-21-028745 · form4.xml · nonDerivative · entry 1 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,845 F1 · security: Includes unvested Restricted Stock Units granted prior to appointment as Section 16 Officer. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:10 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 3,604 | $408.14 | $1,470,936.56 |
DisclosureSEC source: 0001127602-21-028729 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,150 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:09 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 982 | $408.14 | $400,793.48 |
DisclosureSEC source: 0001127602-21-028728 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,274 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:05 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 97 | $408.14 | $39,589.58 |
DisclosureSEC source: 0001127602-21-028726 · form4.xml · nonDerivative · entry 2 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,387 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:07 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 723 | $408.14 | $295,085.22 |
DisclosureSEC source: 0001127602-21-028727 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,462 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:02 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
Tax withholdingCommon Stock | 434 | $408.14 | $177,132.76 |
DisclosureSEC source: 0001127602-21-028725 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,323 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:01 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
Tax withholdingCommon Stock | 264 | $408.14 | $107,748.96 |
DisclosureSEC source: 0001127602-21-028724 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,789 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 21:59 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 446 | $408.14 | $182,030.44 |
DisclosureSEC source: 0001127602-21-028723 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,015 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 21:55 UTC |
Dadswell CharlesSVP & General Counsel
|
Tax withholdingCommon Stock | 739 | $408.14 | $301,615.46 |
DisclosureSEC source: 0001127602-21-028722 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 3,919 Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 21:53 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 191 | $408.14 | $77,954.74 |
DisclosureSEC source: 0001127602-21-028721 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,488 Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 483 | $417.62 | $201,710.46 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 7 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,679 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 200 | $416.48 | $83,296.00 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 6 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,162 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F7 · price: Weighted average sale price representing 200 shares sold ranging from $416.11 to $417.08 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 393 | $413.24 | $162,403.32 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 5 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,362 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 393 shares sold ranging from $413.12 to $413.55 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 366 | $412.15 | $150,846.90 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 4 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,755 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 366 shares sold ranging from $412.04 to $412.40 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 645 | $411.47 | $265,398.15 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 3 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,121 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 645 shares sold ranging from $411.03 to $411.71 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 639 | $410.47 | $262,290.33 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,766 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 639 shares sold ranging from $410.01 to $410.91 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 22:11 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 200 | $409.28 | $81,856.00 |
DisclosureSEC source: 0001127602-21-028415 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,405 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $409 to $409.565 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 20:33 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
SaleCommon Stock | 100 | $414.35 | $41,435.00 |
DisclosureSEC source: 0001127602-21-027953 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,256 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 21:27 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 2,926 | $423.00 | $1,237,698.00 |
DisclosureSEC source: 0001127602-21-027761 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,605 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 20:48 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 314 | $411.00 | $129,054.00 |
DisclosureSEC source: 0001127602-21-027652 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 4,658 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:50 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 173 | $414.70 | $71,743.10 |
DisclosureSEC source: 0001127602-21-027452 · form4.xml · nonDerivative · entry 5 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,531 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 173 shares sold ranging from $414.24 to $415.20 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:50 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 154 | $413.52 | $63,682.08 |
DisclosureSEC source: 0001127602-21-027452 · form4.xml · nonDerivative · entry 4 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,704 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 154 shares sold ranging from $413.01 to $413.88 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:50 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 1,051 | $412.28 | $433,306.28 |
DisclosureSEC source: 0001127602-21-027452 · form4.xml · nonDerivative · entry 3 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,858 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 1,051 shares sold ranging from $412 to $412.83 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:50 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 948 | $411.38 | $389,988.24 |
DisclosureSEC source: 0001127602-21-027452 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,909 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 948 shares sold ranging from $410.98 to $411.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 21:50 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 600 | $410.42 | $246,252.00 |
DisclosureSEC source: 0001127602-21-027452 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,857 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 600 shares sold ranging from $409.96 to $410.93 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 22:29 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 151 | $411.22 | $62,094.22 |
DisclosureSEC source: 0001127602-21-027096 · form4.xml · nonDerivative · entry 5 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,457 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F6 · price: Weighted average sale price representing 151 shares sold ranging from $411.045 to $411.46 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Cancel Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 22:29 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 709 | $410.52 | $291,058.68 |
DisclosureSEC source: 0001127602-21-027096 · form4.xml · nonDerivative · entry 4 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,608 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 709 shares sold ranging from $410 to $410.985 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Cancel Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 22:29 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 893 | $409.48 | $365,665.64 |
DisclosureSEC source: 0001127602-21-027096 · form4.xml · nonDerivative · entry 3 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,317 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 893 shares sold ranging from $408.98 to $409.915 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Cancel Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 22:29 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 750 | $408.33 | $306,247.50 |
DisclosureSEC source: 0001127602-21-027096 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,210 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 750 shares sold ranging from $407.89 to $408.67 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Cancel Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.